Pamela Gilmore, APRN
Nurse Practitioner · Conway, SCNPI 1922564194
Payments from drug & device makers
Across 129 payments — averaging $32.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$423
- Bayer$337
- Novo Nordisk$325
- Johnson & Johnson$278
- Teleflex LLC$272
- Urovant Sciences Inc$247
- plus $2K from 29 others
What the payments were for
- Travel & lodging$2255%
- Food & beverage$3,91292%
- Education$992%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 16 | $423 |
| Bayer | 6 | $337 |
| Novo Nordisk | 3 | $325 |
| Johnson & Johnson | 9 | $278 |
| Teleflex LLC | 3 | $272 |
| Urovant Sciences Inc | 2 | $247 |
| Sumitomo Pharma America, Inc. | 13 | $239 |
| AbbVie | 11 | $213 |
| AstraZeneca | 2 | $177 |
| Bioprotect Medical, Inc. | 3 | $174 |
| Myriad Genetic Laboratories, Inc. | 8 | $134 |
| Progenics Pharmaceuticals, Inc. | 1 | $127 |
| Antares Pharma, Inc. | 7 | $123 |
| GSK | 1 | $121 |
| Insmed, Inc. | 1 | $116 |
| Cvrx, Inc. | 1 | $114 |
| Endo Pharmaceuticals Inc. | 7 | $113 |
| Ferring Pharmaceuticals Inc. | 5 | $109 |
| 180 Medical, Inc. | 3 | $82 |
| Dendreon Pharmaceuticals LLC | 3 | $75 |
| Boston Scientific | 3 | $62 |
| Myovant Sciences Inc. | 3 | $53 |
| Kowa Pharmaceuticals America, Inc. | 3 | $40 |
| Olympus America Inc. | 1 | $37 |
| Verity Pharmaceuticals Inc. | 2 | $31 |
| Rochester Medical Corporation | 2 | $30 |
| Tolmar, Inc. | 1 | $28 |
| Laborie Medical Technologies Corp. | 1 | $25 |
| Clarus Therapeutics Inc. | 2 | $24 |
| Merck | 1 | $23 |
| ABC Home Medical Supply, Inc. | 1 | $21 |
| Endo USA, Inc. | 1 | $19 |
| Hollister Incorporated | 1 | $16 |
| Blue Earth Diagnostics | 1 | $16 |
| Procept Biorobotics Corporation | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GEMTESA$247
- UroLift System$225
- MYRBETRIQ$214
- PYLARIFY$127
- BIOPROTECT BALLOON IMPLANT SYSTEM$125
- Kerendia$121
- RYBELSUS$119
- Arikayce$116
- Barostim Neo System$114
- Wegovy$111
- BREZTRI$103
How this compares
$4,235 in reported general payments places this provider in the 90th percentile of 1,346 nurse practitioner providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 69 | $70,249 |
| GemtesaVibegron | 48 | $43,163 |
| Testosterone | 41 | $9,852 |
| Tamsulosin Hcl | 372 | $6,988 |
| Solifenacin Succinate | 81 | $5,084 |
| Testosterone Cypionate | 115 | $4,908 |
| TlandoTestosterone Undecanoate | 11 | $4,866 |
| Estradiol | 45 | $3,414 |
| Potassium Citrate ErPotassium Citrate | 19 | $1,964 |
| Silodosin | 11 | $1,928 |
| Cephalexin | 121 | $1,703 |
| Finasteride | 111 | $1,696 |
| Methenamine Hippurate | 20 | $1,609 |
| Doxycycline Hyclate | 154 | $1,470 |
| Oxybutynin Chloride ErOxybutynin Chloride | 73 | $1,469 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $423 | $70,24969 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $239 | $43,16348 claims |
| Antares Pharma, Inc.Tlando | $123 | $4,86611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,346 nurse practitioner providers in South Carolina.
Other nurse practitioner in Conway
- Deborah HippConway$12K
- Jenna DavisColumbia$202K
- David WiltGreenville$90K
- Whitney ReedCharleston$54K
- Mary JohnsonCharleston$34K
- Amanda HareCharleston$30K
- Kellie McLainCharleston$28K
- Colleen BoydSummerville$21K
- Mae BurtonGreenville$21K
- Melissa BramanteColumbia$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.